Newly established firm puts down roots in Denmark

US pharmaceutical company MSD has established a spinout company, Organon, which will have an office in Copenhagen. Organon focuses on women's health.
Jennifer Olovson, head of Nordics, Organon. | Photo: Organon/PR
Jennifer Olovson, head of Nordics, Organon. | Photo: Organon/PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT AND DANIEL FRANK CHRISTENSEN

Pharmaceutical group MSD, known as Merck in the US and Canada, has now officially launched its spinout company Organon. It will have offices all over the world, including in Copenhagen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading